X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (34) 34
humans (30) 30
microbiology (26) 26
infectious diseases (21) 21
microbial sensitivity tests (20) 20
drug resistance (18) 18
anti-bacterial agents - pharmacology (17) 17
antibiotics (16) 16
neisseria gonorrhoeae - drug effects (16) 16
drug resistance, bacterial (15) 15
gonorrhea (15) 15
male (15) 15
infections (14) 14
pharmacology & pharmacy (13) 13
united-states (13) 13
azithromycin (12) 12
drug resistance in microorganisms (12) 12
female (12) 12
bacteria (11) 11
neisseria gonorrhoeae (11) 11
gonorrhea - drug therapy (10) 10
cephalosporins (9) 9
genes (9) 9
sexually transmitted diseases (9) 9
surveillance (9) 9
adult (8) 8
antimicrobial resistance (8) 8
azithromycin - pharmacology (8) 8
emergence (8) 8
gonorrhea - microbiology (8) 8
immunology (8) 8
mutation (8) 8
prevalence (7) 7
gonorrhea - epidemiology (6) 6
health aspects (6) 6
research (6) 6
staphylococcus infections (6) 6
united states (6) 6
anti-bacterial agents - therapeutic use (5) 5
bacterial proteins - genetics (5) 5
cefixime (5) 5
cephaloridine (5) 5
disease transmission (5) 5
dna, bacterial - genetics (5) 5
drug therapy (5) 5
epidemiology (5) 5
genotype (5) 5
hawaii (5) 5
methicillin-resistant staphylococcus aureus - genetics (5) 5
methicillin-resistant staphylococcus aureus - isolation & purification (5) 5
moxalactam (5) 5
mrsa (5) 5
neisseria gonorrhoeae - genetics (5) 5
neisseria gonorrhoeae - isolation & purification (5) 5
original research (5) 5
penicillin (5) 5
reduced susceptibility (5) 5
staphylococcus aureus (5) 5
strains (5) 5
united states - epidemiology (5) 5
ceftriaxone (4) 4
chlamydia (4) 4
diseases-treatment-guidelines (4) 4
dosage and administration (4) 4
drug therapy, combination (4) 4
genes, bacterial (4) 4
high-level resistance (4) 4
macrolides - pharmacology (4) 4
medicine, general & internal (4) 4
nose - microbiology (4) 4
patient outcomes (4) 4
polymerase chain reaction (4) 4
resistance (4) 4
staphylococcal infections - microbiology (4) 4
susceptibility (4) 4
young adult (4) 4
anti-infective agents - pharmacology (3) 3
antiinfectives and antibacterials (3) 3
antimicrobial agents (3) 3
article (3) 3
azithromycin - therapeutic use (3) 3
bacterial infections and mycoses (3) 3
biochemical phenomena, metabolism, and nutrition (3) 3
cephalosporins - pharmacology (3) 3
children (3) 3
ciprofloxacin (3) 3
decreased susceptibility (3) 3
disease control (3) 3
drinking water (3) 3
escherichia-coli (3) 3
failure (3) 3
gram-negative bacteria (3) 3
haemophilus influenzae - drug effects (3) 3
identification (3) 3
infection (3) 3
medical treatment (3) 3
men (3) 3
methicillin-resistant staphylococcus aureus - classification (3) 3
nasal colonization (3) 3
neisseria-gonorrhoeae (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Sexually Transmitted Infections, ISSN 1368-4973, 07/2019, Volume 95, Issue Suppl 1, p. A291
BackgroundDesigning diagnostic tools to perform phenotypic antimicrobial susceptibility testing (AST) at the point-of-care (POC) is a vital step in tackling... 
Antimicrobial agents | Gonorrhea | Antibiotics | Penicillin
Journal Article
Sexually Transmitted Infections, ISSN 1368-4973, 07/2019, Volume 95, Issue Suppl 1, p. A297
BackgroundIn order to increase the number of gonococcal isolates available for antimicrobial susceptibility surveillance, we expanded indications for GC... 
Surveillance
Journal Article
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 6/2013, Volume 56, Issue 11, pp. 1539 - 1545
Journal Article
Sexually Transmitted Infections, ISSN 1368-4973, 07/2019, Volume 95, Issue Suppl 1, p. A300
BackgroundNucleic acid amplification testing (NAAT) has replaced culture as the predominant test for Neisseria gonorrhoeae (GC). However, antimicrobial... 
Journal Article
Sexually Transmitted Infections, ISSN 1368-4973, 07/2019, Volume 95, Issue Suppl 1, p. A40
BackgroundThe duration of untreated extragenital gonococcal (GC) and chlamydial infection (CT) infection is not well defined.MethodsFrom March 2016 to December... 
Infections
Journal Article
Sexually Transmitted Infections, ISSN 1368-4973, 07/2019, Volume 95, Issue Suppl 1, p. A49
BackgroundCDC guidelines recommend gentamicin for the treatment of gonorrhea in cephalosporin-allergic patients. The efficacy of gentamicin in the treatment of... 
Clinical trials | Enrollments | Gonorrhea
Journal Article
AJIC: American Journal of Infection Control, ISSN 0196-6553, 2011, Volume 39, Issue 8, pp. 628 - 632
Journal Article
Sexually Transmitted Infections, ISSN 1368-4973, 07/2019, Volume 95, Issue Suppl 1, p. A258
BackgroundLittle is known about the natural history of rectal and pharyngeal Mycoplasma genitalium (MG).MethodsFrom March 2016 to December 2018, we enrolled... 
Infections
Journal Article
Sexually Transmitted Infections, ISSN 1368-4973, 07/2019, Volume 95, Issue Suppl 1, p. A147
BackgroundRectal CT is increasingly recognized as a common infection among women, even in the absence of anal sex. Little is known about the prevalence or... 
Infections | Condoms
Journal Article
Sexually Transmitted Infections, ISSN 1368-4973, 07/2019, Volume 95, Issue Suppl 1, p. A296
BackgroundPublic Health – Seattle & King County (PHSKC) participates in Strengthening the U.S. Response to Resistant Gonorrhea (SURRG), funded by the Centers... 
Journal Article
Sexually Transmitted Infections, ISSN 1368-4973, 07/2019, Volume 95, Issue Suppl 1, p. A359
BackgroundAzithromycin resistance in Neisseria gonorrhoeae has been attributed to several resistance-associated mutations including mutations in the 23S rRNA... 
Antibiotics | Genotype & phenotype | Mutation
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 09/2017, Volume 65, Issue 6, pp. 918 - 923
Background. The Centers for Disease Control and Prevention (CDC) currently recommends dual therapy with ceftriaxone and azithromycin for gonorrhea to ensure... 
Antimicrobial drug resistance | Gonorrhea | AGAR DILUTION | UNITED-STATES | antimicrobial drug resistance | INFECTIOUS DISEASES | 1ST STRAIN | CEFIXIME | ETEST | gonorrhea | JAPAN | SURVEILLANCE PROJECT | MICROBIOLOGY | IMMUNOLOGY | Humans | Middle Aged | Ceftriaxone - pharmacology | Male | Neisseria gonorrhoeae - enzymology | Microbial Sensitivity Tests | Young Adult | Anti-Bacterial Agents - therapeutic use | Drug Resistance, Multiple, Bacterial | Adult | Female | beta-Lactamases - metabolism | Drug Therapy, Combination | Neisseria gonorrhoeae - genetics | Penicillins - pharmacology | Gonorrhea - microbiology | Neisseria gonorrhoeae - drug effects | Gonorrhea - transmission | Tetracycline - pharmacology | Ciprofloxacin - pharmacology | Hawaii | Gonorrhea - drug therapy | Azithromycin - pharmacology | Contact Tracing | Ceftriaxone - therapeutic use | Azithromycin - therapeutic use | Anti-Bacterial Agents - pharmacology | Drug resistance in microorganisms | Neisseria gonorrhoeae | Patient outcomes | Azithromycin | Reports | Ceftriaxone sodium | Dosage and administration | Research | Ceftriaxone | Therapy | Level (quantity) | Genomic analysis | Genomics | Agar | Drug resistance | Disease control | Patients | Antiinfectives and antibacterials | Sexually transmitted diseases | Dilution | Antibiotics | Cephalosporins | Penicillin | Clusters | Antimicrobial resistance | Ciprofloxacin | Index Medicus
Journal Article
Journal Article
Journal Article
Emerging Infectious Diseases, ISSN 1080-6040, 10/2017, Volume 23, Issue 10, pp. 1657 - 1663
Journal Article